VELAGLUCERASE ALFA

2052 reported adverse events

Drug classes: Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]

These side effects are most commonly reported by patients taking VELAGLUCERASE ALFA:

# Side effect Count
0 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 212
1 PRODUCT DOSE OMISSION ISSUE 198
2 COVID-19 167
3 FATIGUE 154
4 DEATH 127
5 PYREXIA 114
6 FALL 112
7 MALAISE 111
8 WEIGHT INCREASED 106
9 HEADACHE 105
See all common reactions for VELAGLUCERASE ALFA

VELAGLUCERASE ALFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHITOTRIOSIDASE DECREASED 2 1.0000
1 CHITOTRIOSIDASE ABNORMAL 1 0.5000
2 BONE CRISIS 1 0.2500
3 BONE MARROW HARVEST 1 0.1667
4 STATUS DYSTONICUS 2 0.1333
5 CHITOTRIOSIDASE INCREASED 4 0.0656
6 ANGIOTENSIN CONVERTING ENZYME DECREASED 1 0.0588
7 SELENIUM DEFICIENCY 2 0.0476
8 PUERPERAL PYREXIA 2 0.0400
9 COLD BURN 1 0.0357
See all enriched reactions for VELAGLUCERASE ALFA